Improving decisions for colorectal cancer screening based on life expectancy

Improving colorectal cancer screening decisions through consideration of life expectancy

NIH-funded research Cleveland Clinic Lerner Com-Cwru · NIH-11047229

This study is looking to help doctors make better decisions about colorectal cancer screening for older adults aged 76 to 85 by taking into account how long they might live, so that patients can get the right care based on their health and needs.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCleveland Clinic Lerner Com-Cwru NIH-funded
Lab location1 site (Cleveland, United States)
Project IDNIH-11047229 on NIH RePORTER

What this research studies

This research aims to enhance colorectal cancer screening decisions by considering patients' life expectancy, particularly for those aged 76 to 85. It addresses the challenge that many physicians face in determining whether older adults should undergo screening, given the risks and benefits involved. The study will develop clinical decision support tools to help physicians make informed choices about screening for patients with varying health statuses and life expectancies. By focusing on individual patient circumstances, the research seeks to optimize screening practices and reduce unnecessary procedures.

Who could benefit from this research

Good fit: Ideal candidates for this research include older adults aged 76 to 85 who are considering colorectal cancer screening and have varying health conditions.

Not a fit: Patients with a life expectancy of less than 10 years may not benefit from this research as the focus is on optimizing screening for those who are likely to live longer.

Why it matters

Potential benefit: If successful, this research could lead to more personalized and effective colorectal cancer screening recommendations, potentially improving patient outcomes.

How similar studies have performed: Previous research has indicated that personalized approaches to cancer screening can improve patient outcomes, suggesting that this study's focus on life expectancy is a promising and relevant area of investigation.

Where this research is happening

Cleveland, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions American Cancer Societyanti-cancer therapy
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.